InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

VYGR Clue Score26
United States Fiscal year ends December CIK 0001640266 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

99
Insider
Date
Role
Action
Shares
Price
Amount
Todd Alfred Carter
10 Feb 2026
Chief Scientific Officer
Sell
3,525
$3.85
$13.57K
Alfred Sandrock
10 Feb 2026
President and CEO
Sell
12,192
$3.78
$46.09K
Robin Swartz
10 Feb 2026
COO & Cbo
Sell
4,569
$3.85
$17.59K
Toby Ferguson
18 Aug 2025
Chief Medical Officer
Sell
19,000
$3.73
$70.87K
Alfred Sandrock
2 Apr 2025
President and CEO
Sell
10,885
$3.43
$37.34K
Toby Ferguson
2 Apr 2025
Chief Medical Officer
Sell
10,086
$3.43
$34.59K
Robin Swartz
20 Feb 2025
COO & Cbo
Sell
3,894
$4.25
$16.55K
Alfred Sandrock
20 Feb 2025
President and CEO
Sell
11,702
$4.24
$49.62K
Todd Alfred Carter
20 Feb 2025
Chief Scientific Officer
Sell
3,305
$4.26
$14.08K
Sandell Jacquelyn Fahey
11 Feb 2025
Chief Legal Officer
Sell
4,358
$4.45
$19.39K
Alfred Sandrock
11 Feb 2025
President & CEO
Sell
16,644
$4.45
$74.07K
Robin Swartz
11 Feb 2025
COO & Cbo
Sell
6,950
$4.45
$30.93K
Todd Alfred Carter
11 Feb 2025
Chief Scientific Officer
Sell
5,413
$4.45
$24.09K
Todd Alfred Carter
14 Jan 2025
Chief Scientific Officer
Sell
1,191
$5.13
$6.11K
Robin Swartz
14 Jan 2025
COO & Cbo
Sell
3,087
$5.09
$15.71K
Robin Swartz
23 Dec 2024
COO&Cbo
Sell
6,500
$5.65
$36.73K
Sandell Jacquelyn Fahey
2 Oct 2024
Chief Legal Officer
Sell
5,999
$5.82
$34.91K
Alfred Sandrock
2 Apr 2024
President and CEO
Sell
12,115
$9.86
$119.45K
Robin Swartz
2 Apr 2024
Chief Operating Officer
Sell
1,357
$9.88
$13.41K
Todd Alfred Carter
21 Feb 2024
Chief Scientific Officer
Sell
3,365
$7.47
$25.14K
Peter P. Pfreundschuh
21 Feb 2024
Chief Financial Officer
Sell
3,764
$7.46
$28.08K
Alfred Sandrock
21 Feb 2024
President and CEO
Sell
13,033
$7.46
$97.23K
Robin Swartz
21 Feb 2024
Chief Operating Officer
Sell
3,966
$7.45
$29.55K
Todd Alfred Carter
20 Feb 2024
Chief Scientific Officer
Sell
602
$7.68
$4.62K
Todd Alfred Carter
17 Jan 2024
Chief Scientific Officer
Sell
1,266
$7.18
$9.09K
Robin Swartz
17 Jan 2024
Chief Operating Officer
Sell
2,543
$7.15
$18.18K
Peter P. Pfreundschuh
3 Oct 2023
Chief Financial Officer
Sell
13,567
$6.99
$94.83K
Robin Swartz
3 Apr 2023
Chief Operating Officer
Sell
1,259
$7.83
$9.86K
Alfred Sandrock
3 Apr 2023
President and CEO
Sell
7,437
$7.83
$58.23K
Robert W. Hesslein
20 Mar 2023
Senior VP & General Counsel
Sell
4,410
$7.76
$34.22K
Robin Swartz
20 Mar 2023
Chief Operating Officer
Sell
3,654
$7.76
$28.36K
Todd Alfred Carter
20 Mar 2023
Chief Scientific Officer
Sell
2,193
$7.76
$17.02K
Robin Swartz
15 Mar 2023
Chief Operating Officer
Sell
15,373
$8.20
$126.06K
Todd Alfred Carter
17 Feb 2023
Chief Scientific Officer
Sell
738
$7.45
$5.50K
Robert W. Hesslein
17 Feb 2023
Senior VP & General Counsel
Sell
3,297
$7.45
$24.56K
Robert W. Hesslein
13 Feb 2023
Senior VP & General Counsel
Sell
2,868
$7.67
$22.00K
Todd Alfred Carter
13 Feb 2023
Chief Scientific Officer
Sell
797
$7.67
$6.11K
Third Rock Ventures III, L.P.
1 Feb 2023
10% owner
Sell
128,642
$9.32
$1.20M
Third Rock Ventures III, L.P.
31 Jan 2023
10% owner
Sell
185,000
$9.25
$1.71M
Third Rock Ventures III, L.P.
30 Jan 2023
10% owner
Sell
75,000
$9.03
$677.25K
Third Rock Ventures III, L.P.
27 Jan 2023
10% owner
Sell
50,000
$9.02
$451.00K
Third Rock Ventures III, L.P.
25 Jan 2023
10% owner
Sell
50,000
$9.22
$461.00K
Third Rock Ventures III, L.P.
24 Jan 2023
10% owner
Sell
100,000
$9.27
$927.00K
Third Rock Ventures III, L.P.
23 Jan 2023
10% owner
Sell
55,000
$9.06
$498.30K
Third Rock Ventures III, L.P.
20 Jan 2023
10% owner
Sell
100,000
$9.15
$915.00K
Robin Swartz
17 Jan 2023
Chief Operating Officer
Sell
792
$10.34
$8.19K
Robin Swartz
17 Jan 2023
Chief Operating Officer
Sell
1,396
$9.57
$13.36K
Todd Alfred Carter
17 Jan 2023
Chief Scientific Officer
Sell
400
$10.34
$4.14K
Todd Alfred Carter
17 Jan 2023
Chief Scientific Officer
Sell
706
$9.57
$6.76K
Robert W. Hesslein
17 Jan 2023
Senior VP & General Counsel
Sell
792
$10.34
$8.19K
Robert W. Hesslein
17 Jan 2023
Senior VP & General Counsel
Sell
1,396
$9.57
$13.36K
EcoR1 Capital, LLC
11 Jan 2023
10% owner
Sell indirect
110,000
$8.50
$934.62K
EcoR1 Capital, LLC
10 Jan 2023
10% owner
Sell indirect
336,400
$8.05
$2.71M
EcoR1 Capital, LLC
9 Jan 2023
10% owner
Sell indirect
456,000
$7.67
$3.50M
Todd Alfred Carter
6 Jan 2023
Chief Scientific Officer
Sell
388
$6.41
$2.49K
Third Rock Ventures III, L.P.
25 Aug 2022
10% owner
Sell
200,000
$6.22
$1.24M
Third Rock Ventures III, L.P.
24 Aug 2022
10% owner
Sell
149,972
$6.09
$913.33K
Third Rock Ventures III, L.P.
16 Aug 2022
10% owner
Sell
128,456
$6.04
$775.87K
Third Rock Ventures III, L.P.
15 Aug 2022
10% owner
Sell
135,808
$6.04
$820.28K
Third Rock Ventures III, L.P.
12 Aug 2022
10% owner
Sell
348,007
$6.12
$2.13M
Michael J Higgins
14 Jul 2022
Director
Sell
13,891
$6.70
$93.07K
Glenn Pierce
14 Jul 2022
Director
Sell
9,512
$6.70
$63.73K
Robert W. Hesslein
4 Apr 2022
Senior VP & General Counsel
Sell
2,786
$8.25
$22.98K
Robin Swartz
4 Apr 2022
Chief Operating Officer
Sell
1,527
$8.25
$12.60K
Julie Burek
21 Mar 2022
VP, Finance
Sell
31
$8.68
$269.08
Julie Burek
21 Mar 2022
VP, Finance
Sell
2,618
$8.29
$21.70K
Robert W. Hesslein
21 Mar 2022
Senior VP & General Counsel
Sell
58
$8.68
$503.44
Robert W. Hesslein
21 Mar 2022
Senior VP & General Counsel
Sell
4,897
$8.29
$40.60K
Robin Swartz
21 Mar 2022
Chief Operating Officer
Sell
51
$8.68
$442.68
Robin Swartz
21 Mar 2022
Chief Operating Officer
Sell
4,362
$8.29
$36.16K
Julie Burek
17 Feb 2022
VP, Finance
Sell
789
$3.55
$2.80K
Robert W. Hesslein
17 Feb 2022
Senior VP & General Counsel
Sell
4,100
$3.55
$14.56K
Julie Burek
11 Feb 2022
VP, Finance
Sell
361
$3.36
$1.21K
Robert W. Hesslein
11 Feb 2022
Senior VP & General Counsel
Sell
3,252
$3.36
$10.93K
Julie Burek
12 Jan 2022
VP, Finance
Sell
265
$3.06
$810.90
Julie Burek
3 Jan 2022
VP, Finance
Sell
3,063
$2.83
$8.67K
Omar Khwaja
21 May 2021
See remarks
Sell
3,516
$4.03
$14.17K
Robert W. Hesslein
5 Apr 2021
Senior VP & General Counsel
Sell
3,292
$4.95
$16.30K
Omar Khwaja
11 Feb 2021
See remarks
Sell
3,475
$7.55
$26.24K
Robert W. Hesslein
11 Feb 2021
Senior VP & General Counsel
Sell
3,186
$7.55
$24.05K
Allison Dorval
11 Feb 2021
Chief Financial Officer
Sell
3,186
$7.55
$24.05K
Andre Turenne
11 Feb 2021
President & CEO
Sell
7,977
$7.55
$60.23K
Allison Dorval
12 Jan 2021
Chief Financial Officer
Sell
2,942
$8.62
$25.36K
Andre Turenne
12 Jan 2021
President & CEO
Sell
10,443
$8.62
$90.02K
Omar Khwaja
21 May 2020
See remarks
Sell
3,500
$12.96
$45.36K
Robert W. Hesslein
3 Apr 2020
Senior VP & General Counsel
Sell
3,091
$8.51
$26.30K
Andre Turenne
21 Jan 2020
President & CEO
Sell
10,705
$13.36
$143.02K
Matthew P. Ottmer
21 Jan 2020
Chief Operating Officer
Sell
3,724
$13.36
$49.75K
Allison Dorval
21 Jan 2020
Chief Financial Officer
Sell
3,128
$13.36
$41.79K
Bernard Ravina
10 Apr 2018
Chief Medical Officer
Sell
2,451
$18.38
$45.05K
Bernard Ravina
12 Mar 2018
Chief Medical Officer
Sell
2,451
$25.16
$61.67K
Bernard Ravina
12 Feb 2018
Chief Medical Officer
Sell
2,451
$18.24
$44.71K
Bernard Ravina
10 Jan 2018
Chief Medical Officer
Sell
3,630
$16.40
$59.53K
Bernard Ravina
11 Dec 2017
Chief Medical Officer
Sell
5,490
$13.63
$74.83K
Bernard Ravina
10 Nov 2017
Chief Medical Officer
Sell
5,490
$13.26
$72.80K
Bernard Ravina
10 Oct 2017
Chief Medical Officer
Sell
10,980
$20.33
$223.22K
Bernard Ravina
11 Sep 2017
Chief Medical Officer
Sell
10,980
$14.30
$157.01K
Bernard Ravina
5 Sep 2017
Chief Medical Officer
Sell
5,490
$10.00
$54.90K
Bernard Ravina
20 Jul 2017
Chief Medical Officer
Sell
5,490
$10.00
$54.90K
Show all 123 transactions →

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 7
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 13,599,620
Sales filed before the plan box existed 67
History held since 18 Nov 2015